Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.29+0.86 (+13.37%)
At close: 04:00PM EDT
7.28 -0.01 (-0.14%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 535.35M
Enterprise value -229.03M
Trailing P/E 4.69
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.61
Price/book (mrq)0.75
Enterprise value/revenue -0.65
Enterprise value/EBITDA -1.65

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-68.98%
S&P500 52-week change 3-3.35%
52-week high 346.91
52-week low 35.31
50-day moving average 36.40
200-day moving average 314.53

Share statistics

Avg vol (3-month) 3834.09k
Avg vol (10-day) 3784.99k
Shares outstanding 583.26M
Implied shares outstanding 6N/A
Float 869.09M
% held by insiders 110.52%
% held by institutions 171.22%
Shares short (28 Apr 2022) 41.96M
Short ratio (28 Apr 2022) 43.8
Short % of float (28 Apr 2022) 43.11%
Short % of shares outstanding (28 Apr 2022) 42.36%
Shares short (prior month 30 Mar 2022) 42.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 34.49%
Operating margin (ttm)39.38%

Management effectiveness

Return on assets (ttm)10.57%
Return on equity (ttm)19.27%

Income statement

Revenue (ttm)351.37M
Revenue per share (ttm)4.24
Quarterly revenue growth (yoy)295.20%
Gross profit (ttm)184.16M
EBITDA 138.41M
Net income avi to common (ttm)121.19M
Diluted EPS (ttm)1.37
Quarterly earnings growth (yoy)467.10%

Balance sheet

Total cash (mrq)764.37M
Total cash per share (mrq)9.18
Total debt (mrq)197k
Total debt/equity (mrq)0.03
Current ratio (mrq)13.58
Book value per share (mrq)8.55

Cash flow statement

Operating cash flow (ttm)-87M
Levered free cash flow (ttm)-127.65M